Denis Chem Lab Limited has scheduled its 45th Annual General Meeting (AGM) for September 25, 2026, and fixed September 18, 2026, as the record date for determining dividend entitlements for FY26. The company emphasized that physical shareholders must update their Know Your Customer (KYC) details with the Registrar and Transfer Agent (RTA) to receive dividends electronically, as mandated by SEBI regulations. Failure to update PAN, nomination, contact details, bank account information, or signatures will restrict dividend payments to electronic mode only.

The Board of Directors, in a meeting held on July 29, 2026, approved the convening of the AGM via Video Conference (VC) or Other Audio Visual Means (OAVM), in compliance with Ministry of Corporate Affairs (MCA) General Circular No. 03/2025 dated September 22, 2025, and General Circular No. 20/2020 dated May 5, 2020. The meeting will transact business including the reappointment of Dr. Himanshu C. Patel as Managing Director for a three-year term effective August 1, 2026, and the appointment of M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for five financial years from FY27 to FY31.

Shareholder Compliance and Voting

Shareholders holding shares as of the cutoff date for dispatch will receive the AGM notice and Annual Report for FY26 via electronic mode. The notice will also be available on the company’s website at investors.denis.com , BSE Limited’s website, and the Central Depository Services (India) Limited (CDSL) e-voting portal at evotingindia.com .

Remote e-voting will commence at 9:00 a.m. on September 22, 2026, and conclude at 5:00 p.m. on September 24, 2026, in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. E-voting during the AGM itself will remain active for 15 minutes after the meeting’s conclusion. Members attending via VC/OAVM will be counted toward the quorum under Section 103 of the Companies Act, 2013.

Dividend Payment Procedures

The final dividend, if declared, will be paid within 30 days of the AGM to members whose names appear on the register as of September 18, 2026. For demat holders, eligibility is determined by data furnished by National Securities Depository Limited (NSDL) and CDSL. Physical shareholders are required to submit folio numbers, scanned share certificates, self-attested PAN and Aadhaar cards, and bank details with a cancelled cheque to MUFG Intime India Private Limited at investor.helpdesk@in.mpmis.mufg.com . Demat holders must coordinate with their Depository Participants to register bank details and email addresses.

Governance Updates

Dr. Himanshu C. Patel, who holds B.E., M.S., and Ph.D. qualifications, continues his leadership role with over four decades of experience in the medical and pharmaceutical sectors. He currently holds 2,048,137 equity shares in the company. The Nomination and Remuneration Committee recommended his reappointment following the expiration of his previous term on July 31, 2026. M/s. Kashyap R. Mehta & Partners, led by Yash K. Mehta, will conduct the secretarial audit to ensure compliance with SEBI Listing Regulations and the Companies Act, 2013.

Denis Chem Lab reported a net profit of ₹840.93 lakh for the financial year ended March 31, 2026, marking a 4.1% increase from ₹807.58 lakh in the prior year. Revenue from operations grew 4.9% to ₹18,172.04 lakh from ₹17,329.97 lakh in FY25, supported by improved operational performance. The board has recommended a final dividend of ₹2.50 per equity share of ₹10 each for FY26, pending approval at the upcoming Annual General Meeting.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹40.01 lakh, a decline from ₹70.75 lakh in the corresponding period of the previous year. Quarterly revenue from operations stood at ₹4,675.49 lakh, compared to ₹4,138.34 lakh in Q4FY25. Total expenses for the quarter increased to ₹4,615.11 lakh from ₹4,128.95 lakh, primarily due to higher material and employee costs.

The board, in its meeting on May 30, 2026, approved the standalone audited financial results. M/s. Shah & Shah Associates, Chartered Accountants, issued an unmodified opinion on the audited financial results. The company also appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditors to fill a casual vacancy and M/s. Kiran J. Mehta & Co. as Cost Auditors for FY 2026-27.

Financial Performance

The company’s earnings per share (EPS) for the full year improved to ₹6.06 from ₹5.82 in the previous year. Total comprehensive income for FY26 rose to ₹855.06 lakh from ₹820.69 lakh. The finance costs for the year increased to ₹84.07 lakh from ₹51.04 lakh, while depreciation and amortization expenses remained stable at ₹683.55 lakh.

Assets and Liabilities

As of March 31, 2026, the company’s total assets stood at ₹12,482.62 lakh, up from ₹11,227.24 lakh in the previous year. Total equity increased to ₹9,157.33 lakh from ₹8,510.42 lakh. Current liabilities rose to ₹3,166.61 lakh from ₹2,617.25 lakh, largely due to an increase in trade payables and current borrowings.

Cash Flow Statement

Net cash generated from operating activities for FY26 was ₹413.15 lakh, a decrease from ₹1,209.19 lakh in the previous year. Cash used in investing activities was ₹496.50 lakh, while financing activities generated ₹44.20 lakh. Cash and cash equivalents at the end of the year stood at ₹45.88 lakh, down from ₹85.03 lakh at the end of FY25.